Adracalin Antikörper (C-Term)
-
- Target Alle Adracalin (AAAS) Antikörper anzeigen
- Adracalin (AAAS) (Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS))
-
Bindungsspezifität
- AA 360-440, C-Term
-
Reaktivität
- Human, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Adracalin Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Rabbit polyclonal to Aladin.
- Spezifität
- Aladin Polyclonal Antibody detects endogenous levels of Aladin protein.
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from human Aladin
- Isotyp
- IgG
- Top Product
- Discover our top product AAAS Primärantikörper
-
anti-Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) (AA 1-100) antibody
AAAS Reaktivität: Human WB, ELISA, IHC (p) Wirt: Maus Monoclonal 5A1 unconjugated
anti-Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) (AA 322-546) antibodyAAAS Reaktivität: Human WB, IHC Wirt: Maus Monoclonal OTI5B10 unconjugated
anti-Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) (Internal Region) antibodyAAAS Reaktivität: Human WB, IF, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) (AA 287-546) antibodyAAAS Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) (AA 1-546) antibodyAAAS Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) (C-Term) antibodyAAAS Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) (C-Term) antibodyAAAS Reaktivität: Human, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS) (AA 395-425) antibodyAAAS Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB55272 unconjugated
-
- Applikationshinweise
-
WB 1:500-1:2000
ELISA 1:40000 - Kommentare
-
Widely expressed. Particularly abundant expression is found in cerebellum, corpus callosum, adrenal gland, pituitary gland, gastrointestinal structures and fetal lung.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C, and avoid repeat freeze-thaw cycles.
-
- Target
- Adracalin (AAAS) (Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS))
- Andere Bezeichnung
- Aladin (AAAS Produkte)
- Synonyme
- zgc:85873 antikoerper, aladin antikoerper, Aladin antikoerper, AAA antikoerper, AAASb antikoerper, ADRACALA antikoerper, ADRACALIN antikoerper, ALADIN antikoerper, D030041N15Rik antikoerper, GL003 antikoerper, aladin WD repeat nucleoporin antikoerper, achalasia, adrenocortical insufficiency, alacrimia antikoerper, aladin WD repeat nucleoporin L homeolog antikoerper, Aaas antikoerper, aaas antikoerper, aaas.L antikoerper, AAAS antikoerper
- Molekulargewicht
- 60 kDa
- Gen-ID
- 8086
- UniProt
- Q9NRG9
-
